Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2024

Oct 3, 2024

30870_dirs_2024-10-03_1ea6df25-908b-4a06-8051-73a2ced68405.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-10-01

Reporting Person: Harrington Robert Arthur (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-10-01 Common Stock A 237 $52.60 Acquired 15753 Direct

Footnotes

F1: Stock award in lieu of cash retainer payment.